FDA Inspection 1000715 — Metropolitan Reproductive Medicine, P.C.
The FDA completed an inspection of Metropolitan Reproductive Medicine, P.C. on January 27, 2017 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 27, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New York, NY (United States)